US 6423308
Treatment of Kaposi's sarcoma with IL-12
expired A61KA61K38/208A61K48/00
Quick answer
US patent 6423308 (Treatment of Kaposi's sarcoma with IL-12) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/208, A61K48/00, A61P, A61P31/18